Product Information
DAYTIME COLD-FLU RELIEF SFTGL is a generic product labeled by Major Pharmaceuticals, priced at $0.1312 per EA under NDC 00904699544. Its NADAC has been published 339 times since Apr 8, 2020.
Strength
325; 10; 5 mg/1; mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904699544
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/31/2019
Pharmacological Classes
Price Statistics
The NADAC for DAYTIME COLD-FLU RELIEF SFTGL has been published 339 times since Apr 8, 2020, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1312 per EA |
|---|---|
| All-time high | $0.1748 (Apr 12, 2023) |
| All-time low | $0.1096 (May 19, 2021) |
| 52-week high | $0.1346 |
| 52-week low | $0.1270 |
| Median price | $0.1317 |
| Average price | $0.1338 |
| Largest weekly change | -25.5% (May 18, 2022) |
| Weeks tracked | 339 |
| Tracking since | Apr 8, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAYTIME COLD-FLU RELIEF SFTGL?
The current National Average Drug Acquisition Cost (NADAC) for DAYTIME COLD-FLU RELIEF SFTGL, manufactured by Major Pharmaceuticals, is $0.1312 per EA (NDC 00904699544), effective Sep 30, 2026.
How has the price of DAYTIME COLD-FLU RELIEF SFTGL changed over time?
Over the history we have for it, the NADAC for DAYTIME COLD-FLU RELIEF SFTGL has risen 11.1%. It has been tracked across 339 weekly CMS publications since Apr 8, 2020.
What are the highest and lowest recorded NADAC prices for DAYTIME COLD-FLU RELIEF SFTGL?
Since Apr 8, 2020, the NADAC for DAYTIME COLD-FLU RELIEF SFTGL has ranged from a low of $0.1096 (May 19, 2021) to a high of $0.1748 (Apr 12, 2023), with a median of $0.1317 per EA.
Are there cheaper alternatives to DAYTIME COLD-FLU RELIEF SFTGL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DAYTIME COLD-FLU RELIEF SFTGL in a comparable dosage form, but none are currently priced below it.
Who manufactures DAYTIME COLD-FLU RELIEF SFTGL?
DAYTIME COLD-FLU RELIEF SFTGL (NDC 00904699544) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.